-
Weekly Buzz: CYTK Scores First FDA Approval, INSM Ends Rhinosinusitis Study, XOMA Acquires GBIO
20 Dec 2025 08:39 GMT
… respective therapeutic candidates.
• XOMA Royalty and Swedish Orphan Biovitrum … Deal or No Deal
XOMA Royalty to Acquire Generation … Bio
XOMA Royalty Corp. (XOMA) agreed to acquire … . Through the acquisition, XOMA Royalty gains the opportunity …
-
XOMA Royalty Enters into Agreement to Acquire Generation Bio
15 Dec 2025 22:00 GMT
… (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (NASDAQ: XOMA), the biotech royalty … to Generation Bio. About XOMA Royalty Corporation
XOMA Royalty is a biotechnology … or biotechnology companies. When XOMA Royalty acquires the future economics …
-
Why Is XOMA Royalty Stock Sinking Thursday?
11 Dec 2025 19:01 GMT
… 40% improvement.
Background on XOMA–Rezolute Partnership
In 2017, … license agreement with XOMA for RZ358 (formerly XOMA 358) for … sales milestones.
In addition, XOMA was entitled to receive royalties … beginning later this year.
XOMA Royalty received a $5 …
-
XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc
05 Dec 2025 14:00 GMT
… GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (Nasdaq: XOMA), the biotech royalty … , to Mural. About XOMA Royalty Corporation
XOMA Royalty is a biotechnology … or biotechnology companies. When XOMA Royalty acquires the future economics …
-
Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty
26 Nov 2025 14:00 GMT
… transaction agreement between XOMA Royalty Corporation (Nasdaq: XOMA) (“XOMA Royalty”), XRA … statements regarding Mural, XOMA Royalty and Sub’s … and uncertainties related to XOMA Royalty, including those described … attributable to Mural, XOMA Royalty or Sub or …
-
XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V.
21 Nov 2025 12:45 GMT
… GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA Royalty”) (Nasdaq: XOMA) today announced it … respectively, to LAVA. About XOMA Royalty Corporation
XOMA Royalty is a biotechnology … or biotechnology companies. When XOMA Royalty acquires the future economics …
-
XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements
12 Nov 2025 12:30 GMT
… stocks. About XOMA Royalty Corporation
XOMA Royalty is …
17,932
11,645
XOMA ROYALTY CORPORATION
CONDENSED CONSOLIDATED BALANCE …
$
221,277
XOMA ROYALTY CORPORATION
CONDENSED CONSOLIDATED STATEMENTS …
-
LAVA Therapeutics N.V. Shareholders are Reminded to Tender Shares for XOMA Royalty Transaction Before November 12, 2025 Deadline
10 Nov 2025 21:09 GMT
… the proposed transaction with XOMA Royalty Corporation (“XOMA”) (NASDAQ: XOMA). On August 4 … , 2025, XOMA and LAVA announced they … further extended or earlier terminated. XOMA Royalty has filed an amendment …
-
Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisition by XRA 5 Corp., a Wholly Owned Subsidiary of XOMA Royalty
24 Oct 2025 20:25 GMT
… wholly owned subsidiary of XOMA Royalty Corporation (Nasdaq: XOMA) (“XOMA Royalty”). As described … www.muraloncology.com. About XOMA Royalty XOMA Royalty Corporation is a … or biotechnology companies. When XOMA Royalty acquires the future economics …
-
LAVA Therapeutics Stock Drops After Amended Deal With XOMA Royalty
17 Oct 2025 20:18 GMT
… .23 per CVR.
LAVA and XOMA Royalty also agreed to amend … related to the deal with XOMA Royalty on November 7, after … to the proposed transaction with XOMA. XOMA first announced that it would … have gained 56% this year, XOMA stock has risen 30%.
Read …
About
© 1995-2025